Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07421596 · ClinicalTrials.gov registry record · NA
An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System
A NA study of Gut Health and Digestive Health, sponsored by SF Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07421596: Recruiting NA study of Gut Health and Digestive Health, sponsored by SF Research Institute.
NCT07421596 is a NA study of Gut Health and Digestive Health that is actively recruiting participants, run by SF Research Institute. The registered enrollment target is 50 participants, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07421596, a NA study of Gut Health and Digestive Health, is actively recruiting participants, sponsored by SF Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and metabolic balance. Changes in gut microbiota, inflammation, and intestinal barrier function may contribute to digestive symptoms such as bloating, discomfort, altered bowel habits, and reduced well-being. In this study, adult men and women with self-reported gastrointestinal symptoms will consume a dietary supplement system daily for eight weeks. The study will measure changes in gut and digestive health using objective stool-based laboratory biomarkers and validated symptom questionnaires. Stool samples will be collected at baseline and at the end of the study to evaluate markers related to microbial diversity, inflammation, immune activity, digestive function, and intestinal barrier integrity. Participants will also complete questionnaires throughout the study to assess gastrointestinal symptoms and subjective digestive health and well-being. The study will also monitor the safety and tolerability of the dietary supplement system during the study period.
Primary Outcome
Mean change from baseline to Week 8 in gut microbial diversity assessed using stool-based analysis as part of the Gut Zoomer® test.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT PhytoPower 1 and PhytoPower 2
Study Locations (1)
California
- San Francisco Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-02-05 |
| Est. Completion | 2026-04-21 |
| Phase | NA |
What NCT07421596 shows while recruiting
NCT07421596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (12% lower).
The record links to 3 conditions, with Gut Health appearing as the primary indexed condition, and to 1 intervention - of which PhytoPower 1 and PhytoPower 2 is the first listed.
NCT07421596 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07421596 about?
NCT07421596 is a clinical study titled "An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System". This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and m...
What is the current status of trial NCT07421596?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-02-05. Estimated completion is 2026-04-21.
What conditions does trial NCT07421596 study?
This clinical trial studies the following conditions: Gut Health, Digestive Health, Gastrointestinal Symptoms.
What interventions are being tested in trial NCT07421596?
The interventions under investigation include: PhytoPower 1 and PhytoPower 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07421596?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07421596 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07421596's enrollment target sits among peer trials
50 5th of 9 higher than 5 of 9 other Gut Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
RECRUITING · NA
-
The Effect Cranberry-Based Products on the Female Microbiome
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
-
Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability
RECRUITING · NA
-
A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms
RECRUITING · NA
-
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI